相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Impact of Genetic and Pharmacologic Inhibition of Myostatin in a Murine Model of Osteogenesis Imperfecta
Catherine L. Omosule et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2021)
Pharmacological Management of Postmenopausal Osteoporosis: a Level I Evidence Based-Expert Opinion
Filippo Migliorini et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2021)
Inhibition of MSTN signal pathway may participate in LIPUS preventing bone loss in ovariectomized rats
Liang Tang et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2020)
Mouse models for muscular dystrophies: an overview
Maaike van Putten et al.
DISEASE MODELS & MECHANISMS (2020)
GDF11 promotes osteogenesis as opposed to MSTN, and follistatin, a MSTN/GDF11 inhibitor, increases muscle mass but weakens bone
Joonho Suh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Inhibition of myostatin prevents microgravity-induced loss of skeletal muscle mass and strength
Rosamund C. Smith et al.
PLOS ONE (2020)
The elusive promise of myostatin inhibition for muscular dystrophy
Kathryn R. Wagner
CURRENT OPINION IN NEUROLOGY (2020)
Targeting myostatin/activin A protects against skeletal muscle and bone loss during spaceflight
Se-Jin Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
The Failed Clinical Story of Myostatin Inhibitors against Duchenne Muscular Dystrophy: Exploring the Biology behind the Battle
Emma Rybalka et al.
CELLS (2020)
Muscle and serum myostatin expression in type 1 diabetes
Athan G. Dial et al.
PHYSIOLOGICAL REPORTS (2020)
Activin Type II Receptor Blockade for Treatment of Muscle Depletion in Chronic Obstructive Pulmonary Disease A Randomized Trial
Michael I. Polkey et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Denosumab effects on bone density and turnover in postmenopausal women with low bone mass with or without previous treatment
Elena Tsourdi et al.
BONE (2019)
Association of serum bone- and muscle-derived factors with age, sex, body composition, and physical function in community-dwelling middle-aged and elderly adults: a cross-sectional study
Kenta Moriwaki et al.
BMC MUSCULOSKELETAL DISORDERS (2019)
Beyond the Big Five: Investigating Myostatin Structure, Polymorphism and Expression in Camelus dromedarius
Maria Favia et al.
FRONTIERS IN GENETICS (2019)
SERUM MYOSTATIN AND IGF-1 AS GENDER-SPECIFIC BIOMARKERS OF FRAILTY AND LOW MUSCLE MASS IN COMMUNITY-DWELLING OLDER ADULTS
J. Chew et al.
JOURNAL OF NUTRITION HEALTH & AGING (2019)
Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial
Michael G. Hanna et al.
LANCET NEUROLOGY (2019)
Novel ActRIIB ligand trap increases muscle mass and improves bone geometry in a mouse model of severe osteogenesis imperfecta
Josephine T. Tauer et al.
BONE (2019)
Relationship between serum level of growth differentiation factors 8, 11 and bone mineral density in girls with anorexia nervosa
Yali Wu et al.
CLINICAL ENDOCRINOLOGY (2019)
Serum Myostatin Levels Are Higher in Fitter, More Active, and Non-Frail Long-Term Nursing Home Residents and Increase after a Physical Exercise Intervention
Haritz Arrieta et al.
GERONTOLOGY (2019)
Osteogenesis Imperfecta: A Need to Understand Divergent Treatment Outcomes in a Disorder Rich in Heterogeneity
Kenneth M. Kozloff
JOURNAL OF BONE AND MINERAL RESEARCH (2019)
Effect of Anti-TGF-β Treatment in a Mouse Model of Severe Osteogenesis Imperfecta
Josephine T. Tauer et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2019)
Relative abundance of mature myostatin rather than total myostatin is negatively associated with bone mineral density in Chinese
Long-Fei Wu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
SOLUBLE ACTIVIN RECEPTOR TYPE IIB DECOY RECEPTOR DIFFERENTIALLY IMPACTS MURINE OSTEOGENESIS IMPERFECTA MUSCLE FUNCTION
Youngjae Jeong et al.
MUSCLE & NERVE (2018)
Skeletal Response to Soluble Activin Receptor Type IIB in Mouse Models of Osteogenesis Imperfecta
Youngjae Jeong et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2018)
Altered bone-regulating myokine expression in skeletal muscle Of Duchenne muscular dystrophy mouse models
Shumin Zhou et al.
MUSCLE & NERVE (2018)
Brown Adipose Tissue Controls Skeletal Muscle Function via the Secretion of Myostatin
Xingxing Kong et al.
CELL METABOLISM (2018)
Bone mineral density comparison of adolescents with constitutional thinness and anorexia nervosa
Melis Pehlivanturk Kizilkan et al.
JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM (2018)
Effect of exercise on bone in poorly controlled type 1 diabetes mediated by the ActRIIB/Smad signaling pathway
Jin Yang et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2018)
Myostatin serum concentrations are correlated with the severity of knee osteoarthritis
Chang Zhao et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2017)
MYOSTATIN INHIBITOR ACE-031 TREATMENT OF AMBULATORY BOYS WITH DUCHENNE MUSCULAR DYSTROPHY: RESULTS OF A RANDOMIZED, PLACEBO- CONTROLLED CLINICAL TRIAL
Craig Campbell et al.
MUSCLE & NERVE (2017)
Myostatin inhibits osteoblastic differentiation by suppressing osteocyte-derived exosomal microRNA-218: A novel mechanism in muscle-bone communication
Yiwen Qin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Reduced serum myostatin concentrations associated with genetic muscle disease progression
Peter M. Burch et al.
JOURNAL OF NEUROLOGY (2017)
Downregulation of myostatin pathway in neuromuscular diseases may explain challenges of anti-myostatin therapeutic approaches
Virginie Mariot et al.
NATURE COMMUNICATIONS (2017)
Activin A more prominently regulates muscle mass in primates than does GDF8
Esther Latres et al.
NATURE COMMUNICATIONS (2017)
A mouse anti-myostatin antibody increases muscle mass and improves muscle strength and contractility in the mdx mouse model of Duchenne muscular dystrophy and its humanized equivalent, domagrozumab (PF-06252616), increases muscle volume in cynomolgus monkeys
Michael St. Andre et al.
SKELETAL MUSCLE (2017)
Inhibition of GDF8 (Myostatin) accelerates bone regeneration in diabetes mellitus type 2
Christoph Wallner et al.
SCIENTIFIC REPORTS (2017)
Current Understanding of RANK Signaling in Osteoclast Differentiation and Maturation
Jin Hee Park et al.
MOLECULES AND CELLS (2017)
Muscle Function in Osteogenesis Imperfecta Type IV
Louis-Nicolas Veilleux et al.
CALCIFIED TISSUE INTERNATIONAL (2017)
GDF8 inhibits bone formation and promotes bone resorption in mice
Yu-Si Chen et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2017)
Treatment with soluble activin type IIB-receptor improves bone mass and strength in a mouse model of Duchenne muscular dystrophy
Tero Puolakkainen et al.
BMC MUSCULOSKELETAL DISORDERS (2017)
Circulating Growth Differentiation Factor 11/8 Levels Decline With Age
Tommaso Poggioli et al.
CIRCULATION RESEARCH (2016)
Inhibiting myostatin signaling prevents femoral trabecular bone loss and microarchitecture deterioration in diet-induced obese rats
Liang Tang et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2016)
Inhibition of myostatin in mice improves insulin sensitivity via irisin-mediated cross talk between muscle and adipose tissues
J. Dong et al.
INTERNATIONAL JOURNAL OF OBESITY (2016)
Myostatin deficiency partially rescues the bone phenotype of osteogenesis imperfecta model mice
A. K. Oestreich et al.
OSTEOPOROSIS INTERNATIONAL (2016)
Sclerostin Antibody Treatment Improves the Bone Phenotype of Crtap-/- Mice, a Model of Recessive Osteogenesis Imperfecta
Ingo Grafe et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2016)
Muscle-bone interactions: From experimental models to the clinic? A critical update
Michael R. Laurent et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2016)
Decreasing maternal myostatin programs adult offspring bone strength in a mouse model of osteogenesis imperfecta
Arin K. Oestreich et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Myostatin inhibition therapy for insulin-deficient type 1 diabetes
Samantha K. Coleman et al.
SCIENTIFIC REPORTS (2016)
Effects of Type 1 Diabetes on Osteoblasts, Osteocytes, and Osteoclasts
Evangelia Kalaitzoglou et al.
CURRENT OSTEOPOROSIS REPORTS (2016)
Dystrophin-deficient dogs with reduced myostatin have unequal muscle growth and greater joint contractures
Joe N. Kornegay et al.
SKELETAL MUSCLE (2016)
Targeted disruption of sp7 and myostatin with CRISPR-Cas9 results in severe bone defects and more muscular cells in common carp
Zhaomin Zhong et al.
SCIENTIFIC REPORTS (2016)
Myostatin induces interstitial fibrosis in the heart via TAK1 and p38
Nadine Biesemann et al.
CELL AND TISSUE RESEARCH (2015)
Activin A inhibits RANKL-mediated osteoclast formation, movement and function in murine bone marrow macrophage cultures
Tristan W. Fowler et al.
JOURNAL OF CELL SCIENCE (2015)
Role of Activin A and Myostatin in Human Cancer Cachexia
Audrey Loumaye et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Myostatin is a direct regulator of osteoclast differentiation and its inhibition reduces inflammatory joint destruction in mice
Berno Dankbar et al.
NATURE MEDICINE (2015)
Targeted mutations in myostatin by zinc-finger nucleases result in double-muscled phenotype in Meishan pigs
Lili Qian et al.
SCIENTIFIC REPORTS (2015)
Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trial
Clemens Becker et al.
LANCET DIABETES & ENDOCRINOLOGY (2015)
Administration of soluble activin receptor 2B increases bone and muscle mass in a mouse model of osteogenesis imperfecta
Douglas J. DiGirolamo et al.
BONE RESEARCH (2015)
Disease course in mdx:utrophin+/- mice: comparison of three mouse models of Duchenne muscular dystrophy
Abby A. McDonald et al.
PHYSIOLOGICAL REPORTS (2015)
Neuromuscular electrical stimulation prevents muscle disuse atrophy during leg immobilization in humans
M. L. Dirks et al.
ACTA PHYSIOLOGICA (2014)
Substantial skeletal muscle loss occurs during only 5 days of disuse
B. T. Wall et al.
ACTA PHYSIOLOGICA (2014)
Myostatin Regulates Energy Homeostasis in the Heart and Prevents Heart Failure
Nadine Biesemann et al.
CIRCULATION RESEARCH (2014)
Myostatin Regulates Tissue Potency and Cardiac Calcium-Handling Proteins
Melissa F. Jackson et al.
ENDOCRINOLOGY (2014)
First Mouse Model for Combined Osteogenesis Imperfecta and Ehlers-Danlos Syndrome
Frieda Chen et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2014)
Muscle Anatomy and Dynamic Muscle Function in Osteogenesis Imperfecta Type I
Louis-Nicolas Veilleux et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Regulation of brown adipocyte metabolism by myostatin/follistatin signaling
Rajan Singh et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2014)
Muscle-bone interactions: basic and clinical aspects
Luisella Cianferotti et al.
ENDOCRINE (2014)
A myostatin inhibitor (propeptide-Fc) increases muscle mass and muscle fiber size in aged mice but does not increase bone density or bone strength
Phonepasong Arounleut et al.
EXPERIMENTAL GERONTOLOGY (2013)
A single ascending-dose study of muscle regulator ace-031 in healthy volunteers
Kenneth M. Attie et al.
MUSCLE & NERVE (2013)
miR-218 Directs a Wnt Signaling Circuit to Promote Differentiation of Osteoblasts and Osteomimicry of Metastatic Cancer Cells
Mohammad Q. Hassan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Immunolocalization of Myostatin (GDF-8) Following Musculoskeletal Injury and the Effects of Exogenous Myostatin on Muscle and Bone Healing
Moataz Elkasrawy et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2012)
Increased circulating myostatin in patients with type 2 diabetes mellitus
Fang Wang et al.
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES (2012)
Third-Generation Bisphosphonates for Treatment of Sensorineural Hearing Loss in Otosclerosis
Alicia M. Quesnel et al.
OTOLOGY & NEUROTOLOGY (2012)
Plasma and Muscle Myostatin in Relation to Type 2 Diabetes
Claus Brandt et al.
PLOS ONE (2012)
Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease
Liping Zhang et al.
FASEB JOURNAL (2011)
The Amazing Osteocyte
Lynda F. Bonewald
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
HINDLIMB SKELETAL MUSCLE FUNCTION IN MYOSTATIN-DEFICIENT MICE
Bettinaa. Gentry et al.
MUSCLE & NERVE (2011)
Bone is functionally impaired in dystrophic mice but less so than skeletal muscle
Susan A. Novotny et al.
NEUROMUSCULAR DISORDERS (2011)
Medical costs of osteoporosis in the elderly Medicare population
S. W. Blume et al.
OSTEOPOROSIS INTERNATIONAL (2011)
Osteoporosis and fragility fractures
Lidia Sanchez-Riera et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2010)
Variable Bone Fragility Associated With an Amish COL1A2 Variant and a Knock-in Mouse Model
Ethan Daley et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Recombinant Myostatin (GDF-8) Propeptide Enhances the Repair and Regeneration of Both Muscle and Bone in a Model of Deep Penetrant Musculoskeletal Injury
Mark W. Hamrick et al.
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE (2010)
Myostatin (GDF-8) deficiency increases fracture callus size, Sox-5 expression, and callus bone volume
Ethan Kellum et al.
BONE (2009)
Loss-of-Function Mutation in Myostatin Reduces Tumor Necrosis Factor α Production and Protects Liver Against Obesity-Induced Insulin Resistance
Jason J. Wilkes et al.
DIABETES (2009)
Myostatin Inhibition in Muscle, but Not Adipose Tissue, Decreases Fat Mass and Improves Insulin Sensitivity
Tingqing Guo et al.
PLOS ONE (2009)
Osteocytes, mechanosensing and Wnt signaling
Lynda F. Bonewald et al.
BONE (2008)
Clinical, agricultural, and evolutionary biology of myostatin: A comparative review
Buel D. Rodgers et al.
ENDOCRINE REVIEWS (2008)
Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy
R. G. G. Russell et al.
OSTEOPOROSIS INTERNATIONAL (2008)
Tendons of myostatin-deficient mice are small, brittle, and hypocellular
Christopher L. Mendias et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Loss of myostatin (GDF8) function increases osteogenic differentiation of bone marrow-derived mesenchymal stem cells but the osteogenic effect is ablated with unloading
M. W. Hamrick et al.
BONE (2007)
Muscle growth after postdevelopmental myostatin gene knockout
Stephen Welle et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
Lack of myostatin results in excessive muscle growth but impaired force generation
Helge Amthor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Transgenic expression of myostatin propeptide prevents diet-induced obesity and insulin resistance
BQ Zhao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Myostatin propeptide-mediated amelioration of dystrophic pathophysiology
S Bogdanovich et al.
FASEB JOURNAL (2005)
Brief report -: Myostatin mutation associated with gross muscle hypertrophy in a child
M Schuelke et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Bone's mechanostat: A 2003 update
HM Frost
ANATOMICAL RECORD PART A-DISCOVERIES IN MOLECULAR CELLULAR AND EVOLUTIONARY BIOLOGY (2003)
Increased bone mineral density in the femora of GDF8 knockout mice
MW Hamrick
ANATOMICAL RECORD PART A-DISCOVERIES IN MOLECULAR CELLULAR AND EVOLUTIONARY BIOLOGY (2003)
Differential temporal expression of members of the transforming growth factor beta superfamily during murine fracture healing
TJ Cho et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2002)
Regulation of myostatin activity and muscle growth
SJ Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
分享论文
